Skip to main content

Table 2 Binding affinity of C. rotundicauda bioactive compound

From: GC–MS and ADME profile analysis of Carcinoscorpius rotundicauda bioactive compounds and their potential as COVID-19 antiviral

No

Compound

Binding affinity (kcal/mol)

ACE2

RdRp

3CLpro

1

Chloroquine (control drug)

− 5.8

2

Favipiravir (control drug)

− 5.1

3

Boceprevir (control drug)

− 6.7

4

Propanoic acid

− 3.3

− 3.3

− 3.4

5

Toluene

− 4.3

− 3.9

− 4.2

6

1,1,2-trichloroethane

− 2.9

− 2.9

− 2.6

7

Butyl acetate

− 3.8

− 3.9

− 3.5

8

Ethyl benzene

− 4.5

− 4.3

− 4.3

9

p-xylene

− 4.6

− 4.3

− 4.5

10

o-xylene

− 4.5

− 4.2

− 4.3

11

1,1,2,2-tetrachloroethane

− 3.3

− 3.0

− 2.7

12

2-methyl-5-(4′-methylphenyl)sulfonyl-4-nitroimidazole

− 7.0

− 5.9

− 6.8

13

1,2,4-trimethylbenzene

− 5.1

− 4.8

− 4.6

14

Azulene

− 5.4

− 5.0

− 5.2